Drug Profile
Estradiol/progesterone intravaginal ring - Dare Bioscience
Alternative Names: DARE-HRT1; JNP 0201Latest Information Update: 08 Apr 2024
Price :
$50
*
At a glance
- Originator Juniper Pharmaceuticals
- Developer Catalent
- Class Contraceptives; Estradiol congeners; Estrenes; Gonadal steroid hormones; Hormonal contraceptives; Hormonal replacements; Pregnenediones; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Menopausal syndrome
Most Recent Events
- 05 Apr 2024 Dare Bioscience has patents pending for estradiol/progesterone in USA
- 21 Jun 2023 Updated pharmacokinetics and safety data from a phase I/II trial in Menopausal syndrome released by Dare Bioscience
- 11 May 2023 Dare Bioscience plans a phase III trial in Menopausal syndrome in the US in 2023 (Vaginal, Ring)